Anatomic Pathology Market Is Projected To Reach USD 49.1 Billion By 2026, At A CAGR Of 7.0%
Summary
- What the Market Looks Like?
- COVID -19 Impact on Anatomic Pathology Market.
The major factors that are expected to be driving the high content screening market are need for cost containment in pharma R&D, growth in funding for cellular research, and technological advancements in HCS solutions are expected to support the growth of the HCS market during the forecast period
What the Market Looks Like?
[343 Pages Report] The anatomic pathology market is projected to reach USD 49.1 billion by 2026 from USD 35.1 billion in 2021, at a CAGR of 7.0%. The global anatomic pathology market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World (RoW).
COVID -19 Impact on Anatomic Pathology Market
Globally, the COVID-19 outbreak has impacted every aspect of the diagnostics industry, including the anatomic pathology market. In the last few months, the number of patient visits to hospitals has reduced significantly, despite emergency and OPD services being available in hospitals.
Download PDF Brochure @ Anatomic Pathology Market
The growth of the anatomic pathology market is majorly driven by the high incidence of cancer and other target diseases, recommendations for cancer screening, availability of reimbursement, and the growing focus on personalized medicine. In addition, emerging economies such as China, India, and Brazil are expected to offer significant growth opportunities for players operating in the anatomic pathology market during the forecast period.
What are Key Trends in the Market?
The growth of the Anatomic Pathology Market is primarily influenced by the following factors:
- High incidence of cancer and other target diseases
- Recommendations for cancer screening
- Availability of reimbursement
- Growing focus on personalized medicine
- Increasing number of clinical trials pertaining to cancer drugs
- Emerging markets offer lucrative opportunities
Based on application, the anatomic pathology market is segmented into disease diagnostics and medical research. The disease diagnostics segment accounted for a larger share of the market in 2020 due to the rapid growth in the geriatric population and the increasing incidence of cancer and other chronic diseases.
Read more about Anatomic Pathology Market@ Anatomic Pathology Market
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.